MedTrace Logo

Almonds and Health Effects on Metabolism, Vascular Function and Cognition

NCT03419702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-03-04

No results posted yet for this study

Summary

The primary objective of the proposed study is to examine and understand the impact of long-term almond consumption on chronic glucose metabolism in subjects with impaired glucose tolerance and/or impaired fasting glucose.

Conditions

  • PreDiabetes
  • Impaired Glucose Tolerance
  • Impaired Fasting Glucose
  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Almonds

During the intervention period of 5 months, subjects will receive daily 50 gr almonds. Subjects are free to consume the almonds during the day whenever they want to, i.e. there will not be guidelines when to consume the almonds.

Sponsors & Collaborators

  • Almond Board of California

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Jogchum Plat, PhD · Maastricht University

  • Ronald P Mensink, PhD · Maastricht University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2021-12-03
Completion
2021-12-03

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03419702 on ClinicalTrials.gov